Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

Browse

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

GlaxoSmithKline v. Teva: Federal circuit broadens induced infringement to preclude marketing generics for off-patent indications

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Journal indexing and metrics

Journal Homepage Submission guidelines

Restricted access

Research article

First published online June, 2021

GlaxoSmithKline v. Teva: Federal circuit broadens induced infringement to preclude marketing generics for off-patent indications

Volume 17, Issue 2

https://doi.org/10.1177/1741134321999698

Abstract

Get full access to this article

View all access options for this article.

Browse journal

Current issue OnlineFirst All issues

Similar articles

Retricted access

Integrated API Distribution in Europe

Retricted access

Balancing Customer Expectations with cGMP Compliance

Retricted access

The Journal of Generic Medicines – Editorial March 2025

Retricted access

Assessment of knowledge,attitude and practice among pharmacy professionals towards generic medicines in Addis Ababa,Ethiopia